Marker Therapeutics closes $16.1M private placement of stock and warrants

Marker Therapeutics, Inc.

Gross proceeds ~$16.1M from sale of 1,783,805 shares, Series A warrants (5,031,250 shares at $4.00/sh), and pre-funded warrants (3,248,445 shares at $0.001/sh).
Closed December 23, 2024; net proceeds for general corporate purposes and working capital.
Company must seek stockholder approval for warrant share issuance within 90 days; ~27% of stockholders agreed to vote in favor.
Registration rights agreement requires resale registration statement filed by January 14, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.